EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction

Ana M B Amorim iD, Luiz F Piochi, Ana T Gaspar, António J Preto iD, Nícia Rosário-Ferreira iD, Irina S Moreira iD

Chemical Research in Toxicology · 17.06.2024 · 37 (6) · 827-849

DOI: 10.1021/acs.chemrestox.3c00352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, online erschienen am 17.05.2024. Verfasst von Ana M B Amorim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal. Hauptthemen laut MEDLINE: Drug Development, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 143-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Funda??o para a Ci?ncia e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The attrition rate of drugs in clinical trials is generally quite high, with estimates suggesting that approximately 90% of drugs fail to make it through the process. The identification of unexpected toxicity issues during preclinical stages is a significant factor contributing to this high rate of failure. These issues can have a major impact on the success of a drug and must be carefully considered throughout the development process. These late-stage rejections or withdrawals of drug candidates significantly increase the costs associated with drug development, particularly when toxicity is detected during clinical trials or after market release. Understanding drug-biological target interactions is essential for evaluating compound toxicity and safety, as well as predicting therapeutic effects and potential off-target effects that could lead to toxicity. This will enable scientists to predict and assess the safety profiles of drug candidates more accurately. Evaluation of toxicity and safety is a critical aspect of drug development, and biomolecules, particularly proteins, play vital roles in complex biological networks and often serve as targets for various chemicals. Therefore, a better understanding of these interactions is crucial for the advancement of drug development. The development of computational methods for evaluating protein-ligand interactions and predicting toxicity is emerging as a promising approach that adheres to the 3Rs principles (replace, reduce, and refine) and has garnered significant attention in recent years. In this review, we present a thorough examination of the latest breakthroughs in drug toxicity prediction, highlighting the significance of drug-target binding affinity in anticipating and mitigating possible adverse effects. In doing so, we aim to contribute to the development of more effective and secure drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentDrug-Related Side Effects and Adverse ReactionsHumansAnimals

Autor:innen und Institutionen

  • Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
  • CNC-UC─Center for Neuroscience and Cell Biology, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
  • CIBB─Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
  • PhD Programme in Biosciences, Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
  • PURR.AI, Rua Pedro Nunes, IPN Incubadora, Ed C, 3030-199 Coimbra, Portugal.
  • PhD Programme in Experimental Biology and Biomedicine, Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Casa Costa Alemão, 3030-789 Coimbra, Portugal.

ORCID-Profile: Ana M B Amorim, António J Preto, Nícia Rosário-Ferreira, Irina S Moreira

Förderung

  • European Regional Development Fund
  • Funda??o para a Ci?ncia e a Tecnologia

Zitieren

APA

Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S. (2024). Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction. Chemical Research in Toxicology, 37(6), 827-849. https://doi.org/10.1021/acs.chemrestox.3c00352

Vancouver

Amorim AMB, Piochi LF, Gaspar AT, Preto AJ, Rosário-Ferreira N, Moreira IS. Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction. Chemical Research in Toxicology. 2024;37(6):827-849. doi:10.1021/acs.chemrestox.3c00352

BibTeX
@article{Amorim2024,
  author = {Amorim, Ana M B and Piochi, Luiz F and Gaspar, Ana T and Preto, António J and Rosário-Ferreira, Nícia and Moreira, Irina S},
  title = {Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  volume = {37},
  number = {6},
  pages = {827--849},
  doi = {10.1021/acs.chemrestox.3c00352}
}
Kostenlos starten →